Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Azeria Therapeutics has wound down voluntarily four years after being set up to advance University of Cambridge and Cancer Research UK work.

Stanford-StartX Fund-backed Nearpod has agreed to an acquisition by Renaissance Holding.

Boreal Ventures will invest in deep tech companies emerging from ÉTS Montréal’s incubator Centech and the wider Quebec ecosystem.

South China University of Technology spinout POI-Tech is working on industrial internet applications and will use some of the money to expand R&D activities.

Centessa has been formed as a biotech conglomerate with $250m in funding following a ten-way merger, including multiple spinouts.

The firm has launched a fund and accelerator called Boab AI that will be run by Deakin University’s former ventures director Andrew Lai.

MIT’s cancer and infectious disease therapy spinout has added $40m to a round that will support the progression of its lead asset into the clinic.

Xfund is among the backers of a $17m round for ImmuneID, which has been set up to commercialise research from Harvard University and Johns Hopkins University.

Main Sequence Ventures-backed FluroSat has joined forces with its peer Dagan and the combined business will operate from the US as Regrow.